CRTC1 and metabolic disease: Collectively, these findings demonstrate the existence of an intriguing double-negative feedback loop between CRTC1 and miR-34a in the liver, in which CRTC1 protects against metabolic disorders in the liver, at least in part, by suppressing aberrant expression of its own inhibitor, miR-34a.